Skip to main content

Pharma News

Pharma Courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The Dadha Group launched NetMeds.com. Netmeds is the “first-to-market” offering a consolidated, Pan-Indian solution for the quick online purchase and ensured fast delivery of prescriptions medications.  India’s first e-marketplace for pharma in the form of a portal  which offers an impressive selection of both prescription drugs and non-prescription products (OTC) drugs, supplying over 25,000 stock keeping units (SKUs) across India from its first warehousing hub in Chennai.  Prescription medication users will have opportunity to select their required medications from more than 260 drug categories for the chronic conditions, such as diabetes, hypertension and cholesterol control.

  • Jubilant Life Sciences Limited is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of APIs, generics, specialty pharmaceuticals and life science ingredients. It also provides services in contract manufacturing and drug discovery.  US Food and Drug Administration (USFDA) upgraded Jubilant Hollisterstier's pharmaceutical sterile manufacturing facility in Spokane, Washington (USA)  to the status of Voluntary Action Indicated (VAI). This upgradation by the USFDA from Official Action Indicated (OAI) to VAI is indicative of the cGMP status at the facility since receiving the warning letter in 2013.

  • Cluster Development Programme for Pharma Sector (CDS-PS) is launched by Government to provide support to the Pharmaceutical industry in becoming more capable, productive and competitive. End of this financial year, 06 Pharma Clusters are likely to come up of which 03 will be greenfields.

    [adsense:336x280:8701650588]

  • Sun Pharma Advanced Research Company Ltd. (SPARC) has licensed out glaucoma medicine Xelpros (latanoprost BAK-free eye drops) to a subsidiary of Sun Pharma for the US market.

  • Cervical cancer is the fourth commonest cause of cancer among women, and tragically is often diagnosed too late. Cervical cancer is a type of cancer that develops in a woman's cervix (the entrance to the womb from the vagina). It is caused by the human papillomavirus (HPV) which is easily spread by sexual intercourse. Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV). Currently, Cervarix, which with another vaccine, Gardasil, is being rolled out to shield young people from HPV. A new study has found that a single vaccine shot, rather than the recommended triple dose, may be enough to protect women against cervical cancer.  The new research is published in the The Lancet Oncology.

  • Glenmark Pharmaceuticals Inc., USA (Glenmark) get final approval by the United States Food & Drug Administration (FDA) for calcipotriene cream, 0.005 per cent, the therapeutic equivalent of Dovonex cream, 0.005 per cent of Leo Pharma A/S.  Glenmark strategy to start to shipping of calcipotriene cream, 0.005 per cent immediately.

  • A new research claims, Autism Spectrum Disorder More Frequently Observed in Boys Than in Girls. The study was published in the journal Molecular Autism.

    Autism spectrum disorder (ASD) is a condition that affects social interaction, communication, interests and behaviour. The study followed a large sample of boys and girls at high-risk for the disorder and other children at low risk beginning before 18 months of age. One in four high-risk boys were identified with the disorder at three years, compared to one in 10 high-risk girls.

  • Finnish researchers have developed the world's first paper-based drug test that enables a rapid analysis of whether a compound, such as morphine, is present in a given sample. Researchers from VTT Technical Research Centre of Finland used antibodies - produced by methods of molecular biology - as morphine sensing molecules to create the drug test printed on paper.

Subscribe to Pharma News